AWP
ABBV icon

Axis Wealth Partners’s AbbVie ABBV Stock Holding History

Axis Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$461K Buy
1,832
+11
+0.6% +$2.37K 0.22% 110
2026
Q1 		$396K Buy
1,821
+45
+3% +$9.98K 0.21% 118
2025
Q4 		$406K Sell
1,776
-39
-2% -$8.88K 0.22% 118
2025
Q3 		$420K Buy
1,815
+128
+8% +$26.1K 0.25% 108
2025
Q2 		$313K Sell
1,687
-88
-5% -$16.4K 0.21% 115
2025
Q1 		$372K Buy
1,775
+4
+0.2% +$778 0.27% 98
2024
Q4 		$315K Buy
+1,771
New +$326K 0.27% 100

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Axis Wealth Partners's ABBV Position: Q2 2026 in Review

Axis Wealth Partners increased its AbbVie (ABBV) stake by 0.6% in Q2 2026, buying an estimated $2.37K and bringing the position to 1,832 shares worth $461K. The position accounts for 0.22% of the portfolio, ranked #110.

Axis Wealth Partners first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Axis Wealth Partners held 1,832 shares of AbbVie worth $461K as of Q2 2026.
  • Axis Wealth Partners bought 11 AbbVie shares in Q2 2026, an estimated $2.37K.
  • AbbVie made up 0.22% of Axis Wealth Partners's portfolio in Q2 2026, its #110 holding.
  • Axis Wealth Partners first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Axis Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.